JPMorgan analyst Tessa Romero placed shares of Edgewise Therapeutics (EWTX) on “Positive Catalyst Watch” while keeping an Overweight rating on the shares with a $45 price target The firm ...

In a report released today, Biren Amin from Piper Sandler maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report), with a price target of $9.00. The company’s shares closed ...

Leerink Partners analyst Daina Graybosch maintained a Buy rating on Century Therapeutics (IPSC – Research Report) yesterday and set a price target of $13.00. The company’s shares closed ...

CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a self-amplifying mRNA COVID-19 vaccine, for individuals 18 ...

16:23 EST Windtree Therapeutics (WINT) files to sell 40M shares of common stock for holders Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing ...

Evercore ISI analyst Liisa Bayko upgraded Crispr Therapeutics (CRSP) to Outperform from In Line with a price target of $99, up from $60. Upcoming key catalysts could “usher in a new era,” says ...

In a report released today, Sami Corwin from William Blair maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report). The company’s shares closed yesterday at $1.41.

Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on APVO: Aptevo Therapeutics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Sell rating on Crispr Therapeutics AG (CRSP – Research Report), with a price target of $32.00. The company’s shares ...

CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a self-amplifying mRNA COVID-19 vaccine, for individuals 18 ...

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target of $102.00. The company’s shares closed yesterday ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Fate Therapeutics (FATE – Research Report). Leverage the ...